CANC vs. PRVT

Last updated Jul 14, 2026

CANC (Tema Oncology ETF) and PRVT (Tema Listed Private Managers ETF) are both exchange-traded funds - CANC is a Health & Biotech Equities fund actively managed by Tema, while PRVT is a Financials Equities fund actively managed by Tema. Both are actively managed. A 0.60 correlation means they provide meaningful diversification when combined. Both charge a 0.75% expense ratio.

Performance

CANC vs. PRVT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tema Oncology ETF (CANC) and Tema Listed Private Managers ETF (PRVT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CANC

• 1D: -1.73%
• 1M: 9.22%
• 6M: 13.62%
• YTD: 17.91%
• 1Y: 58.70%
• 3Y*: 104.11%
• 5Y*: —
• 10Y*: —

PRVT

• 1D: -0.64%
• 1M: —
• 6M: —
• YTD: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CANC vs. PRVT - Yearly Performance Comparison

	2026 (YTD)
CANC Tema Oncology ETF	-2.13%
PRVT Tema Listed Private Managers ETF	1.68%

Correlation

The correlation between CANC and PRVT is 0.60, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (All Time) Calculated using the full available price history since Jul 6, 2026	0.60

CANC vs. PRVT - Sectors Allocation Comparison

Sectors	CANC	PRVT
Healthcare	100.0%	-
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	-
Industrials	-	-
Real Estate	-	100.0%
Technology	-	-
Utilities	-	-

Return for Risk

CANC vs. PRVT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CANC

CANC Risk / Return Rank: 92
CANC Sharpe Ratio Rank: 93
CANC Sortino Ratio Rank: 92
CANC Omega Ratio Rank: 86
CANC Calmar Ratio Rank: 95
CANC Martin Ratio Rank: 92

PRVT

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CANC vs. PRVT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tema Oncology ETF (CANC) and Tema Listed Private Managers ETF (PRVT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CANC	PRVT	Difference
Sharpe ratio: Return per unit of total volatility	2.60	—	—
Sortino ratio: Return per unit of downside risk	3.62	—	—
Omega ratio: Gain probability vs. loss probability	1.41	—	—
Calmar ratio: Return relative to maximum drawdown	6.34	—	—
Martin ratio: Return relative to average drawdown	17.26	—	—

Drawdowns

CANC vs. PRVT - Drawdown Comparison

The maximum CANC drawdown since its inception was -97.53%, which is greater than PRVT's maximum drawdown of -2.95%. Use the drawdown chart below to compare losses from any high point for CANC and PRVT.

Drawdown Indicators

	CANC	PRVT	Difference
Max Drawdown Largest peak-to-trough decline	-97.53%	-2.95%	-94.58%
Max Drawdown (1Y) Largest decline over 1 year	-9.30%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-30.27%	—	—
Current Drawdown Current decline from peak	-51.12%	-0.83%	-50.29%
Average Drawdown Average peak-to-trough decline	-72.70%	-0.82%	-71.88%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.41%	—	—

Volatility

Volatility by Period

	CANC	PRVT	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.48%	—	—
Volatility (6M) Calculated over the trailing 6-month period	16.50%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	22.78%	31.64%	-8.86%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	277.14%	31.64%	+245.50%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	277.14%	31.64%	+245.50%

CANC vs. PRVT - Expense Ratio Comparison

Both CANC and PRVT have an expense ratio of 0.75%.

Dividends

CANC vs. PRVT - Dividend Comparison

CANC's dividend yield for the trailing twelve months is around 0.05%, while PRVT has not paid dividends to shareholders.

Position	TTM	2025	2024	2023
CANC Tema Oncology ETF	0.05%	0.06%	3.00%	0.56%
PRVT Tema Listed Private Managers ETF	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both CANC and PRVT in my portfolio?

CANC and PRVT have a correlation of 0.60, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, CANC or PRVT?

Both ETFs have the same 0.75% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CANC or PRVT?

CANC and PRVT have the same expense ratio: 0.75% per year.

Which ETF pays a higher dividend yield, CANC or PRVT?

CANC has the higher dividend yield at 0.05%, compared with 0.00% for PRVT.

What is the main difference between CANC and PRVT?

CANC is categorized as Health & Biotech Equities, while PRVT is Financials Equities.